The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Wed, July 6, 2022 | 02:57
-------------------------
S. Korea mulling importing Ebola drug from Japan
Posted : 2014-08-10 11:28
Updated : 2014-08-10 11:28
Print Preview
Font Size Up
Font Size Down
South Korea said Sunday it is considering importing an Ebola medicine from Japan amid ongoing measures to block the entry of the deadly virus that has gripped West Africa.

No Ebola cases have been reported in South Korea, but nearly 1,000 people, mostly in West Africa, have died from Ebola hemorrhagic fever since the first outbreak in March.

"In order to prepare for a potential outbreak of Ebola hemorrhagic fever in the country, we are mulling importing Fuji Film's Ebola treatment, which is likely to get the quickest approval from the U.S. Food and Drug Administration," said the Ministry of Food and Drug Safety.

The drug ministry said it may allow the Japanese company to officially sell the medication in South Korea. The ministry may also give a nod to a limited supply of the medicine in emergency cases, it added.

The antivirus treatment, which is currently under a clinical trial, was first developed as an influenza cure. A recent test involving laboratory mice showed that the drug is effective in curing Ebola hemorrhagic fever.

A test result for infected monkeys is set to be released next month. The United States has remarked that it will proceed to authorize the treatment once the animal tests are complete.

The ministry said it will continue to monitor the epidemic and the authorization of the Fuji Film treatment in the U.S. as well as European countries. (Yonhap)

 
LG
  • Fashionista first lady draws polarized reactions
  • Price-conscious consumers flock to fresh food sales
  • Korea's inflation growth hits nearly 24-year high in June on fuel costs
  • Child porn website operator gets 2-yr prison term for concealing criminal proceeds
  • Son Heung-min recalls experiencing racism in Germany, rejoicing at revenge in World Cup upset
  • 6 dead, 30 wounded in shooting at Chicago-area July 4 parade
  • US bill expresses concerns over proposed abolishment of Korean ministry of equality
  • USFK member accused of alleged DUI on motorcycle
  • Korea to expand nuclear power generation to 30% of total by 2030
  • Korea begins transporting country's 1st lunar orbiter to US for Aug. launch
  • Maroon 5's world tour image with Rising Sun design causes stir Maroon 5's world tour image with Rising Sun design causes stir
  • [INTERVIEW] How Frank Wildhorn became most popular musical composer in Korea [INTERVIEW] How Frank Wildhorn became most popular musical composer in Korea
  • [INTERVIEW] Yoon Doo-joon juggles music and acting for series 'Never Give Up' [INTERVIEW] Yoon Doo-joon juggles music and acting for series 'Never Give Up'
  • Enhypen returns with more intense music and performances Enhypen returns with more intense music and performances
  • Korea box office tops 15 mil. admissions in June Korea box office tops 15 mil. admissions in June
DARKROOM
  • Afghanistan earthquake killed more than 1,000

    Afghanistan earthquake killed more than 1,000

  • Divided America reacts to overturn of Roe vs. Wade

    Divided America reacts to overturn of Roe vs. Wade

  • Namaste: Yogis to celebrate International Yoga Day

    Namaste: Yogis to celebrate International Yoga Day

  • Poor hit harder by economic crisis

    Poor hit harder by economic crisis

  • Roland Garros 2022

    Roland Garros 2022

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group